title: Updates from the Sixth International Congress 'Psoriasis: from Gene to Clinic', the Queen Elizabeth II Conference Centre, London, U.K., 1-3 December 2011.
abstract: The 15 years between the First International Congress 'Psoriasis: from Gene to Clinic' and the Sixth Congress held in London from 1 to 3 December 2011 have seen extraordinary progress in the sciences that are relevant to psoriasis and therapeutics that have transformed its treatment. Over this time, 'Psoriasis: from Gene to Clinic' has emerged as the premier conference for clinicians and scientists interested in this field. Its popularity is attested to by the 450 registered delegates from the U.K. and around the world, which necessitated a change of venue to the excellent facilities of the Queen Elizabeth II Conference Centre. Although the content has evolved over the years, the structure of this 3-day conference has remained similar. The first day was given to genetics, comorbidities and outcome measures. Immunology and immunity were covered on the second day and therapeutics on the third. The stature of the three keynote lecturers and eight invited speakers was truly world class and their presentations were interspersed with 23 free communications. Here we review highly selected personal highlights of the meeting that we hope will be of general interest.
authors.affiliation: Western Infirmary, Glasgow G11 6NT, UK.
authors.forename: K
authors.initials: K
authors.lastname: Shams
authors.forename: A D
authors.initials: AD
authors.lastname: Burden
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015897:Comorbidity; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy / Q000235:genetics / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal